Latest updates for Biosneds Apigensol

Fresh curated links around BioSNEDS ApigenSol are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Suannutra seals US distribution rights for TetraSOD
  • ApexGO: AI-Driven Approach to Faster Antibiotic Discovery
  • Apogee Therapeutics: Targeting Atopic Dermatitis

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fnbnews.com /2 weeks ago

Suannutra seals US distribution rights for TetraSOD

Suannutra USA announces it has inked a distribution agreement with Spanish biotech company Fitoplancton Marino S L to provide TetraSOD for the North American market

Read source
genengnews.com /2 weeks ago

ApexGO: AI-Driven Approach to Faster Antibiotic Discovery

Researchers at the University of Pennsylvania developed ApexGO, an AI-powered system that optimizes antimicrobial peptides, rapidly improving antibiotic candidates and identifying...

Read source
seekingalpha.com /1 week ago

Apogee Therapeutics: Targeting Atopic Dermatitis

Read source
webwire.com /1 month ago

Symrise launches Cellexoraâ„¢ MD, a pioneering healthspan ingredient for premium skincare

- - • Next-generation plant-derived true exosomes supporting long-term�skin regeneration, resilience, and vitality - • 100% natural origin ingredient combining...

Read source
genengnews.com /1 month ago

Forecasting Protein Aggregation with an Improved Algorithm

An algorithm for assessing protein aggregation and designing more soluble proteins could help overcome a bottleneck in biologics production. The new, improved software helps manufa...

Read source
pharmexec.com /1 month ago

<![CDATA[Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals ]]>

Read source
prweb.com /1 month ago

Nuritas Brings PeptiStrong® Clinical Momentum and Expanded European Distribution to Vitafoods Europe 2026, Stand 5D30

New clinical trial in elderly adults and growing distributor network signal deepening commitment to European nutraceutical market NEW CANAAN, Conn., April 24, 2026 /PRNewswire-PRWe...

Read source
qchron.com /4 weeks ago

Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalen...

TORONTO, May 1, 2026 /PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), Canada's largest Canadian‑based global health company, today announced that Health Canada has approved...

Read source
food-safety.com /1 month ago

Initial Tests Show Promise for Novel Protein-Based Biopesticide

In a partnership with Syngenta, early laboratory testing demonstrated the activity of novel bioactive ingredients, developed with Biotalys’ AGROBODY technology, against a specific...

Read source
floraldaily.com /1 month ago

Biobest’s new Aphidoletes-System packaging advances aphid control

Biobest's new Aphidoletes-System packaging supports faster population build-up of Aphidoletes aphidimyza. This improves longevity and fecundity for more effective and sustainable a...

Read source
biopharmadive.com /1 month ago

BioAge says early data suggest ‘best-in-class’ potential for inflammation drug

The company has rallied from an earlier setback in obesity thanks to early progress for a drug targeting “NLRP3,” an inflammasome linked to a variety of health conditions. 

Read source
genengnews.com /1 week ago

Skape Bio Unlocks Generalizable GPCR Drugs Using AI Protein Design

David Baker’s latest company is making medicines for a huge protein family once deemed undruggable. A new study generated miniproteins that target GPCRs across a diversity of recep...

Read source
thehindubusinessline.com /1 month ago

Orbicular gets USFDA’s tentative nod for generic Semaglutide Injection in partnership with Apotex

The product will be marketed and commercialised in the United States by Apotex Corp., the ANDA applicant

Read source
fnbnews.com /1 month ago

Syngenta unveils Virestina technology

Syngenta unveiled the global launch of Virestina technology active ingredient metproxybicyclone after Argentina became the first country in the world to approve the technology It i...

Read source
cafepharma.com /1 month ago

Botanix Pharmaceuticals / Sofdra Launch

Botanix Pharmaceuticals / Sofdra Launch Anonymous (not verified) Mon, 04/13/2026 - 05:05 field_thread_url https://cafepharma.com/boards/threads/botanix-pha...

Read source
fiercebiotech.com /2 weeks ago

BioAge CEO has big plans for 'multi-disease impact' of NLRP3 drug across cardio, ocular and CNS

After axing its lead obesity asset last year, BioAge Labs has turned its attention to attacking inflammation in its pursuit of treatments for aging-related illnesses.

Read source
cafepharma.com /1 month ago

Syfovre

Syfovre Anonymous (not verified) Sun, 04/05/2026 - 17:00 field_thread_url https://cafepharma.com/boards/threads/syfovre.690248/ board na...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Biosneds Apigensol

food-safety.com

Recent coverage from public sources
Public source

rssfeeds.webwire.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

fnbnews.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source